Promotion of Long-Term Survival Rate in Patients Receiving Orthotopic Liver Transplantation

严律南,李波,卢实春,文天夫,曾勇,赵继春,程南生,林琦远,马玉奎,赵永恒,胡伟明,田伯乐,周勇,贾乾斌

DOI: https://doi.org/10.3760/cma.j.issn.1007-8118.2003.05.006

2003-01-01

Abstract:Objective To determine clinical measures for promoting long-term survival rate in patients after orthotopic liver transplantation (OLT). Methods The clinical data of 72 patients undergoing OLT in recent 3 years in our hospital were retrospectively analyzed to explore reasons for success and failure. Results Of the 72 patients, 50 were with benign diseases (terminal liver cirrhosis in 34) and 22 with malignant diseases (hepatocellular carcinoma in 19). After the operation, 54 complications including secondary abdominal cavity bleeding (4 cases), severe infection of ascites (2 cases), stress gastric ulcer with bleeding and perforation (1 case), biliary fistula (6 cases), pulmonary infection (21 cases) and fungal infection (5 cases) occurred. There were no primary dysfunction of liver and vascular complications. A follow-up study for 2-41 months showed that there were no biliary complications and chronic liver dysfunction. Six patients died during hospitalization and another 6 died during the follow-up period. The total survival rate was 83.33%. Thirty-two patients survived for over 1 year. The longest survival of 41 months was found in 1 patient. Conclusions Use of new techniques in operation, individualized immunosuppressive therapy, prevention of HBV reinfection and recurrence of liver cancer after transplantation are the key points for raising survival rate in patients after OLT.